PAG
ARKG icon

Private Advisor Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Private Advisor Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
39,844
+18,700
+88% +$596K 0.01% 1101
2026
Q1 		$559K Buy
21,144
+605
+3% +$17.7K ﹤0.01% 1791
2025
Q4 		$595K Buy
20,539
+605
+3% +$18.2K ﹤0.01% 1721
2025
Q3 		$554K Sell
19,934
-1,086
-5% -$27.4K ﹤0.01% 1724
2025
Q2 		$512K Sell
21,020
-40
-0.2% -$877 ﹤0.01% 1673
2025
Q1 		$437K Sell
21,060
-1,393
-6% -$35K ﹤0.01% 1672
2024
Q4 		$529K Sell
22,453
-4,790
-18% -$118K ﹤0.01% 1541
2024
Q3 		$697K Sell
27,243
-16,614
-38% -$423K ﹤0.01% 1446
2024
Q2 		$1.03M Sell
43,857
-4,329
-9% -$109K 0.01% 1190
2024
Q1 		$1.39M Sell
48,186
-4,681
-9% -$141K 0.01% 997
2023
Q4 		$1.73M Buy
52,867
+2,350
+5% +$63.9K 0.01% 833
2023
Q3 		$1.41M Sell
50,517
-530
-1% -$17.3K 0.01% 871
2023
Q2 		$1.74M Sell
51,047
-2,660
-5% -$83.6K 0.02% 780
2023
Q1 		$1.62M Sell
53,707
-1,564
-3% -$48.5K 0.02% 782
2022
Q4 		$1.56K Sell
55,271
-8,622
-13% -$274K ﹤0.01% 1156
2022
Q3 		$2.1M Sell
63,893
-2,736
-4% -$100K 0.02% 606
2022
Q2 		$2.1M Sell
66,629
-18,055
-21% -$631K 0.02% 735
2022
Q1 		$3.89M Sell
84,684
-12,978
-13% -$619K 0.03% 539
2021
Q4 		$5.98M Sell
97,662
-28,411
-23% -$1.96M 0.04% 396
2021
Q3 		$9.42M Buy
126,073
+9,129
+8% +$766K 0.06% 320
2021
Q2 		$10.8M Sell
116,944
-5,528
-5% -$470K 0.09% 220
2021
Q1 		$10.9M Buy
122,472
+16,651
+16% +$1.65M 0.1% 195
2020
Q4 		$9.87M Sell
105,821
-298
-0.3% -$23.7K 0.1% 205
2020
Q3 		$6.62M Buy
106,119
+5,409
+5% +$317K 0.09% 235
2020
Q2 		$5.25M Buy
100,710
+4,865
+5% +$209K 0.07% 254
2020
Q1 		$3M Buy
95,845
+25,646
+37% +$857K 0.06% 315
2019
Q4 		$2.35M Buy
70,199
+22,460
+47% +$714K 0.04% 476
2019
Q3 		$1.41M Sell
47,739
-147
-0.3% -$4.78K 0.02% 656
2019
Q2 		$1.65M Buy
47,886
+20,042
+72% +$642K 0.03% 539
2019
Q1 		$916K Buy
27,844
+1,569
+6% +$46.3K 0.02% 702
2018
Q4 		$630K Buy
26,275
+9,390
+56% +$265K 0.02% 749
2018
Q3 		$564K Buy
+16,885
New +$534K 0.01% 939

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Private Advisor Group's ARKG Position: Q2 2026 in Review

Private Advisor Group increased its ARK Genomic Revolution ETF (ARKG) stake by 88% in Q2 2026, buying an estimated $596K and bringing the position to 39,844 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #1101.

Private Advisor Group first reported a position in ARKG in Q3 2018 and has held it in 32 quarters since. The position peaked at $10.9M in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Private Advisor Group held 39,844 shares of ARK Genomic Revolution ETF worth $1.68M as of Q2 2026.
  • Private Advisor Group bought 18,700 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $596K.
  • ARK Genomic Revolution ETF made up 0.01% of Private Advisor Group's portfolio in Q2 2026, its #1101 holding.
  • Private Advisor Group first reported a position in ARK Genomic Revolution ETF in Q3 2018 and has held it in 32 quarters since.
  • Private Advisor Group's ARK Genomic Revolution ETF position peaked at $10.9M in Q1 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.